A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

Update Il y a 4 ans
Reference: NCT01662492

Woman and Man

Extract

To evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline) as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.


Inclusion criteria

  • Migraine Disorders

Links